Sort
21,453 grants matching “tuberculosis”
Combined Use of Statistical Process Control and Whole Genome Sequencing to Detect and Investigate Nontuberculous Mycobacterial Clusters and Outbreaks
$188,377Arthur W Baker · Duke University · K08 · FY2022 · AI
Combined Use of Statistical Process Control and Whole Genome Sequencing to Detect and Investigate Nontuberculous Mycobacterial Clusters and Outbreaks
$188,377Arthur W Baker · Duke University · K08 · FY2023 · AI
Combined Use of Statistical Process Control and Whole Genome Sequencing to Detect and Investigate Nontuberculous Mycobacterial Clusters and Outbreaks
$188,377Arthur W Baker · Duke University · K08 · FY2024 · AI
Combined Use of Statistical Process Control and Whole Genome Sequencing to Detect and Investigate Nontuberculous Mycobacterial Clusters and Outbreaks
$188,377Arthur W Baker · Duke University · K08 · FY2025 · AI
Novel vaccine boosting candidates for tuberculosis
$188,334Ian M Orme · Colorado State University · R21 · FY2016 · AI
Development of a Listeria monocytogenes - based therapeutic HBV vaccine
$188,315Peter M Lauer · Aduro Biotech · R43 · FY2011 · AI
Correlates of protection from TB and TB/AIDS comorbidity
$188,248Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · R21 · FY2017 · AI
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
$188,241Oregon State University · R01 · FY2002 · AI
Clinic-based Screening to Prevent HIV-associated Cryptococcal Mortality
$188,192Paul K Drain · Massachusetts General Hospital · K23 · FY2014 · AI
Enhancement of Innate Immunity Against Coxiella Pneumonia
$188,138Mark A Jutila · Colorado State University · U54 · FY2009 · AI
Small molecule inhibitors pantothenate synthesis against M. tuberculosis
$188,131Pavel A Petukhov · University Of Illinois At Chicago · R21 · FY2007 · AI
Lead identification of 1,4-benzoxazines as anti-tuberculosis agents
$188,131Scott G. Franzblau · University Of Illinois At Chicago · R21 · FY2007 · AI
Clinical Core
$188,129Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2015 · AI
Structure and mechanism of the ESX secretion system from pathogenic mycobacteria
$188,125Konstantin V Korotkov · University Of Kentucky · R01 · FY2015 · AI
Reinforcing old warriors to treat Mycobacterium kansasii in shorter duration
$188,120Shashi Kant · University Of Texas Hlth Ctr At Tyler · R21 · FY2021 · AI
Iron-dependence of clofazimine activity in mycobacteria
$188,097Martin Inua Voskuil · University Of Colorado Denver · R21 · FY2018 · AI
Metabolic and Immune Consequences of Antibiotic-Related Microbiome Alterations during TB Treatment
$188,082Mamoudou Maiga · Northwestern University · R21 · FY2020 · AI
Infection and Immunity K-12 Science Program: Exploring Knowns/Unknowns via VCRC/Q
$188,030Marlys Hearst Witte · University Of Arizona · R25 · FY2015 · AI
Infection and Immunity K-12 Science Program: Exploring Knowns/Unknowns via VCRC/Q
$188,030Marlys Hearst Witte · University Of Arizona · R25 · FY2017 · AI
Infection and Immunity K-12 Science Program: Exploring Knowns/Unknowns via VCRC/Q
$188,030Marlys Hearst Witte · University Of Arizona · R25 · FY2013 · AI
Infection and Immunity K-12 Science Program: Exploring Knowns/Unknowns via VCRC/Q
$188,030Marlys Hearst Witte · University Of Arizona · R25 · FY2014 · AI
Infection and Immunity K-12 Science Program: Exploring Knowns/Unknowns via VCRC/Q
$188,030Marlys Hearst Witte · University Of Arizona · R25 · FY2016 · AI
Assessing the Mycobacterium tuberculosis carriage state
$187,998Frederick D Quinn · University Of Georgia · R21 · FY2025 · AI
Surfactant Protein-A Regulation of Innate Immunityin Asthma
$187,950Monica Kraft · Duke University · P01 · FY2012 · AI
Immunoproteomic mechanisms of human macrophage resistance to Mycobacterium tuberculosis infection
$187,920Christine M Anterasian · University Of Washington · K08 · FY2025 · AI